Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
01/16/2017 01/17/2017 01/18/2017 01/19/2017 01/20/2017 Date
56.8(c) 57(c) 57(c) 56.8(c) 56 Last
46 171 89 699 70 741 35 621 41 651 Volume
-1.22% +0.35% 0.00% -0.35% -1.41% Change
More quotes
Financials (€)
Sales 2016 570 M
EBIT 2016 175 M
Net income 2016 115 M
Finance 2016 43,7 M
Yield 2016 1,28%
Sales 2017 644 M
EBIT 2017 201 M
Net income 2017 132 M
Finance 2017 148 M
Yield 2017 1,45%
P/E ratio 2016 27,21
P/E ratio 2017 23,58
EV / Sales2016 5,42x
EV / Sales2017 4,64x
Capitalization 3 133 M
More Financials
Company
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics.Its business segments are the geographic locations in which it operates: Italy and the United Kingdom; Europe which comprises Germany, France, Belgium, the Netherlands, Spain, Portugal,... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Latest news on DIASORIN SPA
2016 DIASORIN : Discover Advances in Parathyroid Hormone Testing in DiaSorin Webinar
2016 DIASORIN : Discover the Clinical Significance of 1,25-Dihydroxyvitamin D Testing..
2016 DIASORIN LAUNCHES ITS FIRST MOLECULA : The new simplexa c. difficile direct mole..
2016 DIASORIN : acquisition of DiaSorin and Alere brand materials
2016 DIASORIN : Webinar Showcases Advances in the Diagnosis of Primary Aldosteronism
2016 ROCHE : Automatic Chemiluminescence Immunoassay Analyzer Market 2016 - Roche, Di..
2016 DIASORIN : Reagents, controls and consumables for automatic immunoassay analyzer..
2016 DIASORIN : Webinar Details Parathyroid Hormone Testing in Chronic Kidney Disease..
2016 DIASORIN : acquisition of DiaSorin and Alere brand materials
2016 Kyowa Hakko Kirin Announced Kyowa Medex Acquired approval for Insurance Cover..
More news
Sector news : Diagnostic & Testing Substances
01/17DJLUXOTTICA FOUNDER : A Lifetime of Deals -- WSJ
01/17DJLUXOTTICA : Merger to Create Eyewear Giant -- WSJ
01/17DJWHAT'S NEWS : Business & Finance -- WSJ
01/16 ESSILOR INTL : Luxottica's merger helps Del Vecchio manage family risks
01/16DJLUXOTTICA : Another Big Splash by Italy's Eyewear King
More sector news : Diagnostic & Testing Substances
Latest Tweets
2016DiaSorin, accordo con Beckman Coulter.
1
2016BRIEF-U.S. HHS awards $2.6 mln to Diasorin group to develop Zika test  
2016Diasorin, downgrade di Morgan Stanley (SoldiOnline.it)  
2016$DGX, $DGX DiaSorin To Acquire Focus Diagnostics' Business From Quest Diagnos..
1
2016DiaSorin buys Quest's diagnostic products business for $300M
1
More tweets
Qtime:35
News from SeekingAlpha
2016 Winner And Losers Among Italian Companies
2016 Diasorin SPA ADR 2016 Q3 - Results - Earnings Call Slides
2016 DiaSorin buys Quest's diagnostic products business for $300M
Advertisement
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Full-screen chart
Technical analysis trends DIASORIN SPA
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 58,2 €
Spread / Average Target 3,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Carlo Rosa Chief Executive Officer, Executive Director & GM
Gustavo Denegri Chairman
Piergiorgio Pedron Chief Financial Officer & Senior Corporate VP
Francesco Colotta Chief Medical Officer & Senior Corporate VP
Chen Menachem Even Executive Director & SVP-Commercial Operations
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DIASORIN SPA1.33%3 393
BIOMERIEUX3.56%6 381
SICHUAN MACCURA BIOTEC..--.--%1 752
GUANGZHOU WONDFO BIOTE..--.--%1 476
SHANGHAI KEHUA BIO-ENG..--.--%1 444
MEDICALSYSTEM BIOTECHN..--.--%1 307
More Results